Anti-aging supplement market seen doubling by 2035

Market Research Future projects the global anti-aging supplement market will rise from $5.92 billion in 2025 to $12.54 billion by 2035, driven by aging populations, beauty-from-within demand and broader supplement use. Regulatory clarity around NAD+ precursors is also opening retail channels and accelerating product development.

Why it matters: - The anti-aging supplement category is moving from niche wellness to mass-market consumer health. - The market is projected to grow at a 7.8% CAGR from 2026 to 2035, creating room for premium, evidence-backed products. - Aging demographics, repeat-purchase beauty products and mainstream supplement adoption are supporting demand across regions.

What happened: - Market Research Future projects the global anti-aging supplement market will reach $12.54 billion by 2035, up from $5.92 billion in 2025. - The first year of the forecast period, 2026, is valued at $6.38 billion. - The forecast covers a 2026-2035 period and points to broad growth across formats, ingredients and channels. - The research highlights stronger demand in North America, Europe and Asia-Pacific, with faster growth in emerging markets such as India, Mexico and ASEAN countries.

The details: - Global population aging is a core demand driver, with the World Health Organization expecting one in six people worldwide to be 60 or older by 2030. - The World Health Organization also expects the number of people aged 60 and older to exceed 2.1 billion by 2050. - The United Nations expects the number of people aged 65 and older to surpass those under 18 by the late 2070s. - Consumers are increasingly framing supplements around healthspan, not just disease treatment, which expands the market beyond older buyers. - Beauty-from-within products are gaining credibility through clinical studies, including a randomized trial showing measurable skin elasticity improvement within eight weeks from daily 2.5-gram collagen peptide use. - Roughly three in four U.S. adults take dietary supplements, and healthy aging is among the leading reasons, based on a 2024 Council for Responsible Nutrition survey. - Capsules held 33.4% of the market in 2025 because of familiar dosing and broad retail acceptance. - Powders are the fastest-growing format, with an 11.5% CAGR through 2035, helped by higher collagen doses and daily drink routines. - Gummies are projected to grow at 10.2% CAGR through 2035, supported by convenience and taste. - Tablets generated $1.17 billion in 2025, while softgels held 11.6% of revenue. - Antioxidants, collagen peptides, hyaluronic acid, resveratrol and coenzyme Q10 are the core active ingredient categories. - Women remain the largest target group, while men, seniors, athletes and other health-conscious consumers are adding momentum. - Retail pharmacies remain the dominant distribution channel, while online stores are the fastest-growing channel. - Direct-to-consumer brands have attracted investment because they offer higher margins and tighter customer relationships. - The FDA’s 2025 conclusion that NMN can lawfully be marketed as a dietary supplement removed a major barrier in the U.S. market. - EFSA’s novel food assessment process provides a parallel pathway for NMN in Europe. - North America held about 37.8% of the market in 2025. - The United States accounted for 81.4% of North American share, helped by DSHEA and broad supplement usage. - Canada generated $0.24 billion, supported by Natural Health Products licensing. - Mexico is projected to grow at 8.4% CAGR through 2035. - Europe was the second-largest region at $1.62 billion in 2025. - Germany held 21.6% of European share, while the United Kingdom generated $0.27 billion and France is projected to grow at 6.8% CAGR. - Italy held 11.9% of regional share, Spain generated $0.12 billion in 2025 and the Nordic countries are growing at 7.9% CAGR. - Asia-Pacific is the fastest-growing region, with a 9.6% CAGR through 2035. - China held 34.8% of Asia-Pacific share, Japan generated $0.36 billion in 2025 and India is projected to grow at 12.1% CAGR. - South Korea held 11.6% of regional share, and ASEAN markets are growing at 10.8% CAGR. - South America accounted for 5.1% of the market in 2025, led by Brazil, which held 58.7% of regional share. - Brazil’s growth is supported by ANVISA’s RDC 243/2018 framework and strong collagen demand. - Argentina is projected to grow at 7.6% CAGR through 2035. - The competitive landscape is moderately fragmented, with the top five companies holding an estimated 32% to 38% of global revenue. - Nestlé Health Science said in July 2025 it would prioritize premium lines such as Pure Encapsulations and Vital Proteins. - Niagen Bioscience rebranded in March 2025 to sharpen its focus on NAD+ science.

Between the lines: - Regulatory clarity is becoming a competitive advantage, especially in NAD+ and cellular-health products where earlier uncertainty slowed retail expansion. - Brands with clinical evidence can command more shelf space, higher price points and stronger repeat purchase behavior. - The fastest growth is coming from formats and channels that fit daily routines, including powders, gummies and online subscriptions. - Premium positioning appears to matter more than broad commodity scale as large consumer health companies focus on differentiated product lines.

What's next: - Growth should continue as aging populations expand the addressable consumer base through 2035. - Retailers are likely to keep adding evidence-based anti-aging products as regulatory rules become clearer. - Product innovation is expected to center on collagen blends, NAD+ offerings and formulations that combine multiple active ingredients. - Competition should intensify in online and direct-to-consumer channels as brands try to win repeat buyers with education and subscriptions.

The bottom line: - Anti-aging supplements are shifting from a beauty niche into a global wellness category with clear regulatory tailwinds, strong demographic support and room for premium brands to scale.